A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome
{{output}}
Introduction: The objective of our case series was to assess the change in hemoglobin for adults with myelodysplastic syndrome (MDS) started on a sodium glucose cotransporter 2 inhibitor (SGLT2i) for their diabetes, heart failure... ...
